{"id":"https://openalex.org/W2016682845","doi":"https://doi.org/10.1111/fcp.12023","title":"Interactions between angiotensin AT 1receptor antagonists and second\u2010generation antiepileptic drugs in the test of maximal electroshock","display_name":"Interactions between angiotensin AT 1receptor antagonists and second\u2010generation antiepileptic drugs in the test of maximal electroshock","publication_year":2013,"publication_date":"2013-03-28","ids":{"openalex":"https://openalex.org/W2016682845","doi":"https://doi.org/10.1111/fcp.12023","mag":"2016682845","pmid":"https://pubmed.ncbi.nlm.nih.gov/23551463"},"language":"en","primary_location":{"id":"doi:10.1111/fcp.12023","doi":"https://doi.org/10.1111/fcp.12023","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12023","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental &amp; Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032544808","display_name":"Krzysztof \u0141ukawski","orcid":"https://orcid.org/0000-0002-9610-2532","observed_orcids":["https://orcid.org/0000-0002-9610-2532"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Krzysztof \u0141ukawski","raw_affiliation_strings":["Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075620176","display_name":"Agnieszka Janowska","orcid":"https://orcid.org/0009-0006-2077-1082","observed_orcids":["https://orcid.org/0009-0006-2077-1082"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agnieszka Janowska","raw_affiliation_strings":["Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012035211","display_name":"Tomasz Jakubus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomasz Jakubus","raw_affiliation_strings":["Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078348855","display_name":"Stanis\u0142aw Jerzy Czuczwar","orcid":"https://orcid.org/0000-0003-2879-9945","observed_orcids":["https://orcid.org/0000-0003-2879-9945"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Stanis\u0142aw J. Czuczwar","raw_affiliation_strings":["Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, 20-090 Lublin, Poland","Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, 20-090 Lublin, Poland","institution_ids":["https://openalex.org/I121032520"]},{"raw_affiliation_string":"Department of Physiopathology, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032544808"],"corresponding_institution_ids":[],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":2.3843,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.87442954,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"28","issue":"3","first_page":"277","last_page":"283"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":1.0},{"id":"https://openalex.org/keywords/second-generation-antiepileptic-drugs","display_name":"second-generation antiepileptic drugs","score":0.9620000123977661},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9620000123977661},{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":0.9240000247955322},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/anticonvulsant-drug-interactions","display_name":"anticonvulsant drug interactions","score":0.7950000166893005},{"id":"https://openalex.org/keywords/maximal-electroshock-seizure-test","display_name":"maximal electroshock seizure test","score":0.7829999923706055},{"id":"https://openalex.org/keywords/pharmacokinetic-interactions","display_name":"pharmacokinetic interactions","score":0.8930000066757202},{"id":"https://openalex.org/keywords/pharmacodynamic-interactions","display_name":"pharmacodynamic interactions","score":0.9589999914169312},{"id":"https://openalex.org/keywords/anticonvulsant-potentiation","display_name":"anticonvulsant potentiation","score":0.7099999785423279},{"id":"https://openalex.org/keywords/passive-avoidance-test","display_name":"passive avoidance test","score":0.6200000047683716},{"id":"https://openalex.org/keywords/motor-coordination","display_name":"motor coordination","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7938480973243713},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.7603694200515747},{"id":"https://openalex.org/C2779716603","wikidata":"https://www.wikidata.org/wiki/Q733186","display_name":"Telmisartan","level":3,"score":0.7559517025947571},{"id":"https://openalex.org/C2781176495","wikidata":"https://www.wikidata.org/wiki/Q176301","display_name":"Oxcarbazepine","level":4,"score":0.7550172805786133},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.6431071162223816},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5566869378089905},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.5238492488861084},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.3834162950515747},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35797619819641113},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.3147805333137512},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2831849455833435},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21376541256904602},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.18842852115631104},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0610174834728241},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001362","descriptor_name":"Avoidance Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004597","descriptor_name":"Electroshock","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/fcp.12023","doi":"https://doi.org/10.1111/fcp.12023","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12023","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental &amp; Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:23551463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23551463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1907313955","https://openalex.org/W1964067437","https://openalex.org/W1966837740","https://openalex.org/W1972734453","https://openalex.org/W1984602215","https://openalex.org/W1985018268","https://openalex.org/W1987721729","https://openalex.org/W1991808350","https://openalex.org/W1992355801","https://openalex.org/W1994696430","https://openalex.org/W1998959104","https://openalex.org/W2001317429","https://openalex.org/W2008243276","https://openalex.org/W2016020917","https://openalex.org/W2016359652","https://openalex.org/W2017398416","https://openalex.org/W2019933714","https://openalex.org/W2024550853","https://openalex.org/W2033389202","https://openalex.org/W2042457319","https://openalex.org/W2050613378","https://openalex.org/W2053310281","https://openalex.org/W2065023609","https://openalex.org/W2068925959","https://openalex.org/W2072044976","https://openalex.org/W2075411027","https://openalex.org/W2079039027","https://openalex.org/W2083900220","https://openalex.org/W2092808370","https://openalex.org/W2096739998","https://openalex.org/W2111814093","https://openalex.org/W2113215554","https://openalex.org/W2120273877","https://openalex.org/W2122150294","https://openalex.org/W2126814491","https://openalex.org/W2142910953","https://openalex.org/W2166513726","https://openalex.org/W2259516905","https://openalex.org/W2401188729","https://openalex.org/W2503193180"],"related_works":["https://openalex.org/W2001317429","https://openalex.org/W4236030012","https://openalex.org/W2063304619","https://openalex.org/W3186564453","https://openalex.org/W3113379567","https://openalex.org/W2021827332","https://openalex.org/W2081157408","https://openalex.org/W2126481869","https://openalex.org/W3024337303","https://openalex.org/W2845883090"],"abstract_inverted_index":{"The":[0,33,176,201,227],"anticonvulsant":[1,49,148,205],"activity":[2,50],"of":[3,30,35,43,51,102,114,128,142,150,171,178,203,207,214,229],"angiotensin":[4],"AT1":[5,22,179],"receptor":[6,23,180],"antagonists,":[7],"losartan":[8,44,98,210],"(2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'(1H-tetrazol-5-yl)-biphenil-4-yl)methyl]imidazole)":[9],"and":[10,45,61,91,104,167,224,231],"telmisartan":[11,46,163,230],"(49-[(1,49-dimethyl-29-propyl[2,69-bi-1H-benzimidazo]-19-yl)methyl]-[1,19-biphenyl]-2-carboxylic":[12],"acid),":[13],"has":[14],"been":[15],"reported":[16],"recently.":[17],"It":[18],"is":[19,233],"suggested":[20],"that":[21],"antagonists":[24,181],"may":[25],"affect":[26,187],"the":[27,41,48,68,79,88,95,100,111,136,140,147,190,198,204],"protective":[28,112],"action":[29,113,149,206],"antiepileptic":[31,183],"drugs.":[32],"aim":[34],"this":[36,66,156,218],"study":[37],"was":[38,76,121,158],"to":[39,237],"determine":[40],"influence":[42],"on":[47,212],"some":[52],"second-generation":[53],"antiepileptics":[54],"(lamotrigine":[55],"-":[56,59,63],"LTG,":[57],"oxcarbazepine":[58],"OXC,":[60],"topiramate":[62],"TPM).":[64],"For":[65],"purpose,":[67],"maximal":[69],"electroshock":[70],"seizure":[71],"(MES)":[72],"test":[73,193],"in":[74,87,132,135,160,189,197],"mice":[75],"used.":[77],"Additionally,":[78],"drug":[80],"combinations":[81,177],"were":[82],"checked":[83],"for":[84,221],"adverse":[85],"effects":[86],"passive":[89,191],"avoidance":[90,192],"chimney":[92,199],"tests.":[93],"In":[94],"MES":[96],"test,":[97],"at":[99,139],"doses":[101],"30":[103,143],"50":[105],"mg/kg,":[106],"administered":[107],"intraperitoneally":[108],"(i.p.),":[109],"potentiated":[110],"LTG":[115,129,208],"(P":[116,152,173],"<":[117,153,174],"0.01).":[118,154],"This":[119],"interaction":[120,157],"not":[122,186],"accompanied":[123],"by":[124,209],"a":[125],"significant":[126],"change":[127],"level":[130],"either":[131],"plasma":[133,166],"or":[134,194],"brain.":[137],"Telmisartan":[138],"dose":[141],"mg/kg":[144],"i.p.":[145],"enhanced":[146],"TPM":[151,172,232],"However,":[155],"pharmacokinetic":[159,238],"nature,":[161],"as":[162],"significantly":[164],"increased":[165],"total":[168],"brain":[169],"concentrations":[170],"0.001).":[175],"with":[182],"drugs":[184],"did":[185],"retention":[188],"motor":[195],"coordination":[196],"test.":[200],"potentiation":[202],"probably":[211],"account":[213],"pharmacodynamic":[215],"interactions,":[216],"make":[217],"combination":[219,228],"important":[220],"further":[222],"experimental":[223],"clinical":[225],"studies.":[226],"less":[234],"beneficial":[235],"due":[236],"interactions.":[239]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}